NI
TNGX icon

Nextech Invest’s Tango Therapeutics TNGX Stock Holding History

Nextech Invest’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152M Hold
7,266,081
– – 10.7% 3
2025
Q4 		$64.4M Buy
7,266,081
+1,732,101
+31% +$14.9M 6.22% 3
2025
Q3 		$46.5M Hold
5,533,980
– – 7.08% 4
2025
Q2 		$28.3M Hold
5,533,980
– – 5.36% 4
2025
Q1 		$7.58M Hold
5,533,980
– – 1.76% 11
2024
Q4 		$17.1M Hold
5,533,980
– – 2.77% 7
2024
Q3 		$42.6M Hold
5,533,980
– – 5.98% 5
2024
Q2 		$47.5M Hold
5,533,980
– – 7.99% 3
2024
Q1 		$43.9M Hold
5,533,980
– – 6.97% 6
2023
Q4 		$54.8M Hold
5,533,980
– – 10.21% 4
2023
Q3 		$62.3M Buy
+5,533,980
New +$33.7M 18.88% 2

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Nextech Invest's TNGX Position: Q1 2026 in Review

Nextech Invest held its Tango Therapeutics (TNGX) position steady in Q1 2026 at 7,266,081 shares worth $152M. The position accounts for 10.7% of the portfolio, ranked #3.

Nextech Invest first reported a position in TNGX in Q3 2023 and has held it in 11 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Nextech Invest held 7,266,081 shares of Tango Therapeutics worth $152M as of Q1 2026.
  • Nextech Invest left its Tango Therapeutics share count unchanged in Q1 2026.
  • Tango Therapeutics made up 10.7% of Nextech Invest's portfolio in Q1 2026, its #3 holding.
  • Nextech Invest first reported a position in Tango Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.